Colony Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,106
Closed -$320K 847
2021
Q3
$320K Buy
+1,106
New +$284K 0.01% 671
2020
Q1
Sell
-2,336
Closed -$216K 754
2019
Q4
$216K Buy
+2,336
New +$196K 0.01% 704
2016
Q1
Sell
-2,400
Closed -$68K 544
2015
Q4
$68K Sell
2,400
-40,955
-94% -$1.18M 0.01% 453
2015
Q3
$1.21M Sell
43,355
-285
-0.7% -$10.3K 0.14% 146
2015
Q2
$1.8M Buy
43,640
+750
+2% +$27.5K 0.19% 115
2015
Q1
$1.3M Sell
42,890
-24,360
-36% -$632K 0.14% 125
2014
Q4
$1.33M Sell
67,250
-4,100
-6% -$91.7K 0.14% 152
2014
Q3
$1.42M Sell
71,350
-12,780
-15% -$269K 0.16% 125
2014
Q2
$1.92M Sell
84,130
-4,330
-5% -$77.1K 0.26% 97
2014
Q1
$1.14M Sell
88,460
-23,045
-21% -$330K 0.15% 113
2013
Q4
$1.52M Buy
111,505
+575
+0.5% +$6.87K 0.21% 102
2013
Q3
$1.23M Sell
110,930
-13,050
-11% -$130K 0.24% 87
2013
Q2
$1.02M Buy
+123,980
New +$1.04M 0.2% 84

Other funds holding RGEN

Colony Group's RGEN Position: Q4 2021 in Review

Colony Group sold out of Repligen (RGEN) in Q4 2021, closing a stake of 1,106 shares — an estimated $320K sold.

Colony Group first reported a position in RGEN in Q2 2013 and held it in 13 quarters. The position peaked at $1.92M in Q2 2014. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Colony Group reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Colony Group sold 1,106 Repligen shares in Q4 2021, an estimated $320K.
  • Colony Group first reported a position in Repligen in Q2 2013 and held it in 13 quarters.
  • Colony Group's Repligen position peaked at $1.92M in Q2 2014.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Colony Group's 13F filing for Q4 2021, filed 15 Feb 2022.